The Bid & AskIndependent minds. Open research.
Menu

THE INDEPENDENT RESEARCH DESK / 28 Sep 2026

Research desk / Research profile / MRSH

Inside the research

Marsh & McLennan Companies, Inc.

MRSH Research profile · latest available data

Price overview

$171.12

▲ +1.19 (+0.7%)

52w hi$203.77
52w lo$156.44
Vol3.15M
As of25 Sep 2026

The Verdict

Hold

Our score +0.12

Short+0.16
Medium+0.09
Long+0.10

computed 2026-09-27

Key fundamentals

Marsh & McLennan Companies, Inc.

Financial Services · Insurance Brokers

Market cap$81.66B
Enterprise value$102.59B
Trailing P/E20.87x
Forward P/E15.00x
EV / EBITDA13.22x
P / S (ttm)2.92x
Profit margin14.2%
Return on equity25.9%
Revenue growth+6.2%
Earnings growth+7.3%
Debt / equity145.03

Layer Breakdown

LayerRawContribution
Fundamental+0.25
Sector+0.02
Technical-0.02
Earnings+0.00
Sentiment+0.18

macro × 1.00 · 2026-09-27

Business overview

Marsh & McLennan Companies, Inc., a professional services company, provides advisory services and insurance solutions to clients in the areas of risk, strategy, and people worldwide. The company operates through Risk and Insurance Services, and Consulting segments. The Risk and Insurance Services segment offers risk management services, such as risk management, insurance broking, insurance program management, risk consulting, analytical modeling, and alternative risk financing services. This segment also offers insurance and reinsurance broking, strategic advisory and actuarial services, and analytics solutions. It serves businesses, public entities, insurance companies, associations, professional services organizations, and private clients. The Consulting segment provides health, wealth and career advice, solutions and products; and specialized management, strategic, economic, and brand consulting services. Marsh & McLennan Companies, Inc. was founded in 1871 and is headquartered in New York, New York.

United States · www.corporate.marsh.com

Risk Metrics

Beta vs SPX0.19
Corr SPX0.13
Annual vol22.6%
Annual ret-10.8%
Sharpe-0.48
Max DD-35.6%

Window: 504 trading days (504 obs)

Analyst Coverage

Mean PT$203.10
High / Low$236.00 / $179.00
Median$200.00
Analysts21
Strong Buy3
Buy6
Hold13
Sell0
Strong Sell1

Recent rating actions

2026-05-06Citigroup→ Buy
2026-04-17Keefe, Bruyette & Woods→ Market Perform
2026-04-14B of A Securities→ Underperform
2026-04-13Mizuho→ Neutral
2026-04-09Wells Fargo→ Equal-Weight
2026-04-09JP Morgan→ Overweight

Material Events

DateEvent8-K
2026-07-21Earnings Release, Exhibitsread
2026-06-04Material Agreement, Termination of Agreement…read
2026-05-22Shareholder Voteread
2026-04-16Earnings Release, Exhibitsread
2026-04-14Officer / Director Change, Exhibitsread
2026-03-10Officer / Director Changeread
2026-02-25Officer / Director Changeread
2026-02-19Other Material Event, Exhibitsread
2026-01-29Earnings Release, Exhibitsread
2026-01-14Bylaws Amendmentread
2025-10-16Earnings Release, Exhibitsread
2025-07-17Earnings Release, Exhibitsread

Insider Trades

DateInsiderRoleActionSharesValue
2026-08-06Jones John JudeChief Marketing OfficerSell6.50K$1.25M
2026-07-29Beswick PaulSVP, Chief Information OfSell713$141.17K
2026-07-28South MartinChief Client OfficerSell7.10K$1.35M
2026-07-23Yates Lloyd MSell12.00K$2.11M
2026-06-02Doyle John QPresident and CEOSell16.66K$2.69M
2026-06-02Doyle John QPresident and CEOOption exercise16.66K$1.22M
2026-03-15Tomlinson PatrickPresident and CEO, MercerWithheld for tax627$107.94K
2026-03-15Tomlinson PatrickPresident and CEO, MercerOption exercise1.23K—
2026-03-11Jones John JudeChief Marketing OfficerSell2.36K$410.07K
2026-03-04Doyle John QPresident and CEOOption exercise16.66K—

Flow & Concentration

Insider 180d net-$7.54M
Insider buys / sells0 / 5
Insider biasSellers
13F holders0
Top-5 share0.0%
HHI0 (—)

Dividends

Yield (TTM)1.58%
$ / share (TTM)$2.70
5y CAGR+13.3%

Annual dividend per share

2021$2.00
2022$2.25
2023$2.60
2024$3.05
2025$3.43
2026$1.80

Federal Contracts

AmountAgencyDescription
$422.85MDepartment of Health and Human ServicesNIH PUBLIC INFORMATION AND COMMUNICATION SERVICES (PICS) II
$143.77MDepartment of Health and Human ServicesTORP 2101, PAN RESPIRATORY VIRUS PUBLIC EDUCATION CAMPAIGN SUPPORT SERVICES
$19.98MDepartment of Health and Human ServicesCENTRALIZED MOLECULAR ASSESSMENT OF SARS-COV-2 AND INFLUENZA VIRUS INFECTION AND
$15.10MDepartment of Health and Human ServicesFORS MARSH CONTRACT FOR SOCIAL NORMING OF PEDIATRIC VACCINES CAMPAIGN
$13.51MDepartment of DefensePLANNED MAINTENANCE INTERVAL (PMI)
$12.97MDepartment of DefenseTHE HEALTH PLAN INNOVATIVE SUPPORT (HPIS) PROGRAM SUPPORTS THE DEVELOPMENT AND I
$12.20MDepartment of Homeland SecurityNPAD SUPPORT SERVICES
$12.10MDepartment of DefenseRESEARCH IAW THE SOW - BASE

SEC Filings

DateFormDoc
2026-08-074view
2026-07-314view
2026-07-294view
2026-07-244view
2026-07-218-Kview
2026-07-2110-Qview
2026-06-2211-Kview
2026-06-2211-Kview
2026-06-048-Kview
2026-06-034view
2026-06-034view
2026-06-034view
2026-06-034view
2026-06-034view
2026-06-034view

The Long Run

FY 2009–2025 · 17 years

LineLatestCAGRTrend
Revenue$26.98B+10.3%
Operating income$5.28B+12.1%
Net income$3.76B+20.6%
Cash from ops$5.29B+14.1%

Indices

S&P 500

Recent Sessions

DateOpenHighLowCloseVol
Sep 25$169.95$173.74$169.67$171.123.15M
Sep 24$170.81$171.84$168.92$169.933.20M
Sep 23$169.45$171.52$169.45$170.382.65M
Sep 22$172.85$172.91$167.93$170.013.62M
Sep 21$175.16$175.79$172.72$172.722.86M

Understand the score. Research layers are inputs to a model, and the available data has limits.

Read the methodology →